Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm Phase II Study to Evaluate Efficacy of T-DM1 With Palbociclib in the Treatment of Patients With Metastatic HER2 Positive Breast Cancer

NCT03530696 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT03530696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03530696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm Phase II Study to Evaluate Efficacy of T-DM1 With Palbociclib in the Treatment of Patients With Metastatic HER2 Positive Breast Cancer
Lead sponsor
University of Arizona
Phase
Phase 2
Overall status
Completed
Start date
December 6, 2018
Completion date
December 22, 2022
Enrollment
55 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer stage, her2 positive breast carcinoma, her2-positive breast cancer, metastatic breast cancer, recurrent breast cancer